Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1 and 2 Clinical Trial of ALIMTA® (Pemetrexed) in Combination With Carboplatin in Patients With Recurrent Ovarian or Primary Peritoneal Cancer

NCT00489359 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.

NCT NCT00489359
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00489359 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1 and 2 Clinical Trial of ALIMTA® (Pemetrexed) in Combination With Carboplatin in Patients With Recurrent Ovarian or Primary Peritoneal Cancer
Lead sponsor
Eli Lilly and Company
Phase
Phase 1/2
Overall status
Completed
Start date
July 31, 2005
Completion date
February 28, 2010
Enrollment
86 (actual)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

ovarian cancer, primary peritoneal cancer